May 15, 2019

Powles T et al. Nature Medicine 2019;25:1706–1714.

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

Access publication

You might also be interested by

Brochures

Immunohistochemistry (IHC) Biomarker List

February 29, 2024

Histopathology

More info

Brochures

Cell Therapy

December 15, 2023

Histopathology

More info

Videos

Our Histopathology Laboratories

November 22, 2022

Histopathology

More info